| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/30/2008 | US7429386 Administering botulinum toxin to a non-surgically formed stretch mark or to the vicinity of the non-surgically formed stretch mark |
| 09/30/2008 | US7429385 Isolated, genetic engineered polypeptide |
| 09/30/2008 | US7429384 Autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome and atherosclerosis |
| 09/30/2008 | US7429383 Improves the efficiency of targeting cells to the bone marrow, and/or to modulate hematopoietic progenitor cell function |
| 09/30/2008 | US7429382 Antibodies that bind cell-associated CA 125/O772P and methods of use thereof |
| 09/30/2008 | US7429381 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 09/30/2008 | US7429380 Production of a multimeric protein by cell fusion method |
| 09/30/2008 | US7429379 TNF receptor action modulation |
| 09/30/2008 | CA2473596C Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 09/30/2008 | CA2295604C Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation |
| 09/30/2008 | CA2261989C Recombinant pox virus for immunization against tumor-associated antigens |
| 09/30/2008 | CA2259140C Method of activating dendritic cells |
| 09/30/2008 | CA2082382C Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
| 09/25/2008 | WO2008116219A2 Uses of monoclonal antibody 8h9 |
| 09/25/2008 | WO2008116163A1 Therapeutic drug combinations for treatment of b-cell malignancies |
| 09/25/2008 | WO2008116118A2 Fully human antibodies to gram positive bacteria |
| 09/25/2008 | WO2008116103A2 Stable antibody formulations |
| 09/25/2008 | WO2008116032A1 Compositions and methods for inhibiting tumor cell growth |
| 09/25/2008 | WO2008115785A2 Multivalent avian influenza vaccines and methods |
| 09/25/2008 | WO2008115750A2 Compositions and methods for the treatment of cancer |
| 09/25/2008 | WO2008115641A2 Modular nanoparticles for adaptable vaccines |
| 09/25/2008 | WO2008115631A2 Plant-produced compositions for treating papillomavirus infection and related methods |
| 09/25/2008 | WO2008115610A1 Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer |
| 09/25/2008 | WO2008115525A2 Metal-binding therapeutic peptides |
| 09/25/2008 | WO2008115470A2 Hox-gene expression as a biomarker for igf-1r therapeutics |
| 09/25/2008 | WO2008115415A2 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 09/25/2008 | WO2008115314A2 Flavivirus vaccine vector against influenza virus |
| 09/25/2008 | WO2008115300A1 C-kit phosphorylation in cancer |
| 09/25/2008 | WO2008115254A1 Method of protecting against staphylococcal infection |
| 09/25/2008 | WO2008115199A2 Chimeric virus vaccines |
| 09/25/2008 | WO2008114980A1 Simultaneous diagnostic kit for trichomonas vaginalis and chlamydia trachomatis |
| 09/25/2008 | WO2008114889A1 Oral vaccine |
| 09/25/2008 | WO2008114876A1 A method of treating malignant mesothelioma |
| 09/25/2008 | WO2008114733A1 Anti-claudin-4 antibody |
| 09/25/2008 | WO2008114516A1 Liposome and immunostimulating composition comprising the same |
| 09/25/2008 | WO2008114501A1 Diagnostic agent and therapeutic agent for cancer |
| 09/25/2008 | WO2008114487A1 Therapeutic agent for autoimmune skin disease containing polypeptide as active ingredient |
| 09/25/2008 | WO2008114119A2 P38 inhibitors |
| 09/25/2008 | WO2008113970A2 Peptides |
| 09/25/2008 | WO2008113916A2 Pharmaceutical composition containing antibodies directed against the herv-w envelope |
| 09/25/2008 | WO2008113833A1 Novel human anti-r7v antibodies and uses thereof |
| 09/25/2008 | WO2008113606A1 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use |
| 09/25/2008 | WO2008113185A1 Antagonists of ligands and uses thereof |
| 09/25/2008 | WO2008088426A3 Adherence inhibitor directed to and method of making and using |
| 09/25/2008 | WO2008085518A3 Compositions and methods relating to organ-, tissue-, and cell-specific antibodies |
| 09/25/2008 | WO2008083949A3 Rna-coded antibody |
| 09/25/2008 | WO2008075395A3 Method for the diagnosis and/or monitoring of invasive aspergillosis |
| 09/25/2008 | WO2008057329A3 Method for detecting and controlling cancer |
| 09/25/2008 | WO2008054603A3 Il-17 receptor a antigen binding proteins |
| 09/25/2008 | WO2008048519A3 Antibodies that bind cxcr7 epitopes |
| 09/25/2008 | WO2008047235A3 Methods of treating disorders associated with fat storage |
| 09/25/2008 | WO2008034119A3 Polyalkylene oxides having hindered ester-based biodegradable linkers |
| 09/25/2008 | WO2008033333A3 Il-1 family variants |
| 09/25/2008 | WO2008030616A3 Monitoring cancer stem cells |
| 09/25/2008 | WO2008029138A3 Peptides and methods |
| 09/25/2008 | WO2008026225A3 A vaccine for chikungunya virus infection |
| 09/25/2008 | WO2008021092A3 Trypanosome microsome system and uses thereof |
| 09/25/2008 | WO2008016976A3 Vaccines and methods for controlling adiposity |
| 09/25/2008 | WO2007145941A3 Administration of anti-cd3 antibodies in the treatment of autoimmune diseases |
| 09/25/2008 | WO2007143548A3 Myxoma virus mutants for cancer treatment |
| 09/25/2008 | WO2007130555A3 Augmentation of immune response to cancer vaccine |
| 09/25/2008 | WO2007117410A3 Transgenic animals expressing chimeric antibodies for use in preparing human antibodies |
| 09/25/2008 | WO2007101254A3 Compositions and methods for the treatment of immune system disorders |
| 09/25/2008 | WO2007089753A3 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 09/25/2008 | WO2007065027A3 Carbonic anhydrase ix (g250) antibodies and methods of use thereof |
| 09/25/2008 | WO2007040546A3 Production of recombinant protein pap 31 for the diagnosis and prevention of bartonella bacilliformis infection |
| 09/25/2008 | WO2007034219A3 Modifying leukocyte function |
| 09/25/2008 | WO2006031870A3 Strain independent amplification of pathogens and vaccines thereto |
| 09/25/2008 | WO2005060999A9 Detection of cd20 in therapy of autoimmune diseases |
| 09/25/2008 | US20080235815 Generating transgenic avians via transformation of urogenital systems for use in expression of heterologous genes; bioreactors |
| 09/25/2008 | US20080235814 Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom |
| 09/25/2008 | US20080235813 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells |
| 09/25/2008 | US20080234470 Kcnb: a novel potassium channel protein |
| 09/25/2008 | US20080234468 Isdolated nucleic acids; coding polypeptide; therapy for central nervous system disorders |
| 09/25/2008 | US20080234216 TGF-beta type receptor cDNAs encoded products and uses therefor |
| 09/25/2008 | US20080234215 DNA composition and uses thereof |
| 09/25/2008 | US20080234191 Depleting complement; treatment of diseases such as reperfusion injury, autoimmune diseases, and other diseases of increased complement activation; increasing the efficiency and/or effectiveness of gene therapy; may be chemically linked to an antibody with an affinity for a specific tissue |
| 09/25/2008 | US20080233646 Human DR4 antibodies and uses thereof |
| 09/25/2008 | US20080233637 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 09/25/2008 | US20080233599 Immunogenic glycopeptides, screening, preparation and uses |
| 09/25/2008 | US20080233598 Active and/or passive immunization; accurate early stage, localized tumor detection |
| 09/25/2008 | US20080233560 DNA-transfection system for the generation of infectious influenza virus |
| 09/25/2008 | US20080233559 Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein |
| 09/25/2008 | US20080233556 Cytotonic protein and utlization thereof |
| 09/25/2008 | US20080233181 Nanoparticle adjuvants for sub-unit vaccines |
| 09/25/2008 | US20080233169 Implantable medical device having a coating of a biocompatible polylactone from N-substituted 4-aza-caprolactone |
| 09/25/2008 | US20080233155 Bifidobacterium or Lactobacillus plantarum and/or combination of a corticosteroid with vitamin D3; autoimmune disease |
| 09/25/2008 | US20080233154 Immunoprotective and nontoxic Gram-negative bleb vaccine suitable for paediatric use; Neisseria meningitides; H. influenzae |
| 09/25/2008 | US20080233153 Vaccine compositions and adjuvant |
| 09/25/2008 | US20080233152 Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins Stabilized with Polypeptide Fragments Derived from HIV-TAT |
| 09/25/2008 | US20080233151 Calmodulin and metalloproteinase exotoxins; vaccine; anthrax |
| 09/25/2008 | US20080233150 Respiratory syncytial virus-virus like particle (vlps) |
| 09/25/2008 | US20080233149 Use of Erythropoietin for Enhancing Immune Responses and for Treatment of Lymphoproliferative Disorders |
| 09/25/2008 | US20080233148 Method of Producing Virus |
| 09/25/2008 | US20080233147 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 09/25/2008 | US20080233146 Promoter gene, recombinant turkey herpesvirus having the novel promoter gene, and poultry vaccine including the recombinant herpes virus of turkey |
| 09/25/2008 | US20080233143 Comprising a lipid dendritic cell targeting moiety covalently linked a metal chelating group; immunomodulators; Pam2Cys (S-(2,3-dipalmitate-propyl)cysteine or Pam3Cys (N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]cysteine) linked to trinitrilotriacetic acid |
| 09/25/2008 | US20080233142 Use of penetration enhancers and barrier disruption methods to enhance the immune response of an antigen |
| 09/25/2008 | US20080233141 Chimera of papillomavirus capsid polypeptide L2; cervical cancers and warts; capsomeres |
| 09/25/2008 | US20080233140 Binding Dectin-1 on immune cells with anti-Dectin-1-specific antibodies; rAb proteins; antigen presentation and immune cell activation; vaccines |